| Literature DB >> 31031322 |
Daniela Zambonin1, Francesco Giudici1, Ferdinando Ficari1, Benedetta Pesi1, Cecilia Malentacchi2, Stefano Scaringi1.
Abstract
BACKGROUND: The feasibility of minimally invasive approach for Crohn's disease (CD) is still controversial. However, several meta-analysis and retrospective studies demonstrated the safety and benefits of laparoscopy for CD patients. Laparoscopic surgery can also be considered for complex disease and recurrent disease. The aim of this study was to investigate retrospectively the effect of three minimally invasive techniques on short- and long-term post-operative outcome. PATIENTS AND METHODS: We analysed CD patients underwent minimally invasive surgery in the Digestive Surgery Unit at Careggi University Hospital (from January 2012 to March 2017). Short-term outcome was evaluated with Clavien-Dindo classification and visual analogue scale for post-operative pain. Long-term outcome was evaluated through four questionnaires: Short Form Health Survey (SF-36), Gastrointestinal Quality Of Life Index (GIQLI), Body Image Questionnaire (BIQ) and Hospital Experience Questionnaire (HEQ).Entities:
Keywords: Crohn's disease; minimally invasive surgery; quality of life
Year: 2020 PMID: 31031322 PMCID: PMC7597873 DOI: 10.4103/jmas.JMAS_61_19
Source DB: PubMed Journal: J Minim Access Surg ISSN: 1998-3921 Impact factor: 1.407
Population characteristics
| CVL | SILS | RALS | |
|---|---|---|---|
| Patients, | 63 (70.8) | 16 (18) | 10 (11.2) |
| Gender, | |||
| Male | 31 (49.2) | 10 (62.5) | 2 (20) |
| Female | 32 (50.8) | 6 (37.5) | 8 (80) |
| Median age at diagnosis (years) | 28.1 (11.6-67.2) | 34.8 (14.2-51.5) | 45.4 (22.4-67.8) |
| Median age at surgery (years) | 41.5 (17.2-76.9) | 41.4 (19.5-63.8) | 52.9 (26.9-82.3) |
| Behaviour, | |||
| Stricturing | 47 (74.6) | 8 (50) | 10 (100) |
| Penetrating | 2 (3.2) | 1 (6.3) | - |
| Stricturing and penetrating | 14 (22.2) | 7 (43.8) | - |
| Pre-operative biologics, | 11 (17.5) | 2 (12.5) | 2 (20) |
| Biologics withdrawal period (days) | 47.8 | 16.7 | 45 |
| Pre-operatory corticosteroids, | 35 (55.6) | 7 (43.8) | 4 (40) |
| Mean post-operative stay (days) | 7.0±2.7 | 5.4±0.9 | 6.7±2.3 |
| Median VAS | |||
| D2 | 2 (0-8) | 2 (0-6) | 2.5 (0-5) |
| D3 | 0 (0-8) | 0 (0-6) | 0 (0-3) |
| Complications, | |||
| Grade I | - | 1 (6.3) | - |
| Grade II | 6 (9.5) | - | - |
| Grade III | 4 (6.3) | - | - |
| Nutritional status, | |||
| BMI18 | 12 (19) | 2 (12.5) | 3 (30) |
| ALB30 | 16 (25.4) | 2 (12.5) | 2 (20) |
| WL10 | 20 (31.7) | 3 (18.8) | 4 (40) |
| Redo surgery, | 10 (15.9) | 4 (25) | - |
| Type of anastomosis, | |||
| Mechanical L-L | 21 (33.3) | 1 (6.3) | - |
| Manual L-L isoperistaltic | 34 (53.9) | 7 (43.8) | 7 (70) |
| Kono | 2 (3.2) | 5 (31.3) | - |
| Ileorectal | 1 (1.6) | - | - |
| Coloanal | 1 (1.6) | - | - |
| Mechanical L-L isoperistaltic | 2 (3.2) | 3 (18.8) | 3 (30) |
| Manual colorectal | 1 (1.6) | - | - |
| Terminal ileostomy | 1 (1.6) | - | - |
| Median operative time | 180 (90-385) | 180 (120-230) | 240 (130-385) |
CVL: Conventional laparoscopy, SILS: Single incision laparoscopic surgery, RALS: Robotic-assisted laparoscopic surgery, VAS: Visual analogue scale, BMI: Body mass index, ALB: Albumin, WL: Weight loss
Questionnaires results
| CVL | SILS | RALS | |
|---|---|---|---|
| SF-36, mean±SD | |||
| Physical health | 79±21.2 | 81±19.2 | 55±21.4 |
| General health | 56±20.1 | 62±23.0 | 46±19.3 |
| Psycho-emotional health | 72±22.1 | 75±24.1 | 55±27.8 |
| GIQLI, mean±SD | 107±22.8 | 102±28.6 | 107±22.4 |
| BIQ, mean±SD | 40±6.7 | 38±6.2 | 38±3.7 |
| HEQ, mean±SD | 37±6.7 | 39±6.4 | 43±5.4 |
CVL: Conventional laparoscopy, SILS: Single-incision laparoscopic surgery, RALS: Robotic-assisted laparoscopic surgery, SF-36: Short Form Health Survey-36, SD: Standard deviation, GIQLI: Gastrointestinal Quality of Life Index, BIQ: Body Image Questionnaire, HEQ: Hospital Experience Questionnaire
Complication risk factors
| Risk factors | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | |||
| Gender | ||||
| Male | 1 (reference) | 0.529 | 1 (reference) | 0.103 |
| Female | 1.5 (0.4-5.9) | −1.7 (−5.7-3.4) | ||
| Type of disease | ||||
| Stricturing | 1 (reference) | 0.663 | 1 (reference) | 0.735 |
| Penetrating | 1.4 (0.3-5.9) | 0.3 (2.9-8.6) | ||
| Penetrating + stricturing | 1.4 (0.3-6.9) | −0.4 (−1.6-4.04) | ||
| Pre-operative biologics | ||||
| No | 1 (reference) | 0.860 | 1 (reference) | 0.734 |
| Yes | 1.2 (0.2-6.1) | 0.34 (1.4-4.2) | ||
| Pre-operative corticosteroids | ||||
| No | 1 (reference) | 0.578 | 1 (reference) | 0.435 |
| Yes | 1.5 (0.4-5.6) | 0.8 (3.5-4.5) | ||
| BMI18 | 1.9 (0.5-8.7) | 0.359 | −0.48 (0.6-0.5) | 0.629 |
| ALB30 | 6.9 (1.7-27.9) | 0.006 | 5.35 (1.2-24.7) | 0.031 |
| WL10 | 4.1 (1.1-16.1) | 0.041 | 1.28 (2.9-2.4) | 0.202 |
| Re-do surgery, | 2.6 (0.6-11.8) | 0.201 | 1.34 (3.3-2.9) | 0.181 |
BMI: Body mass index, ALB: Albumin, WL: Weight loss, CI: Confidence interval, HR: Hazard ratio
Visual analogue scale 3 risk factors
| Risk factors | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | |||
| Gender | ||||
| Male | 1 (reference) | 0.969 | 1 (reference) | 0.932 |
| Female | 0.9 (0.3-3.6) | 1.06 (0.2-4.5) | ||
| CVL | 0.9 (0.2-4.0) | 0.954 | 1.0 (0.99-1.01) | 0.503 |
| SILS | 2.2 (0.5-9.5) | 0.302 | 5.4 (0.8-36.8) | 0.081 |
| RALS | - | - | - | - |
| Re-do surgery, | 1.7 (5.4-5.2) | 0.162 | 1.0 (0.9-1.1) | 0.915 |
CVL: Conventional laparoscopy, SILS: Single-incision laparoscopic surgery, RALS: Robotic-assisted laparoscopic surgery, CI: Confidence interval, HR: Hazard ratio
Figure 1Short Form Health Survey-36 questionnaire stratified according to the surgical technique
Figure 4Hospital Experience Questionnaire stratified according to the surgical technique